Beta Drugs Limited

BETA NSE Healthcare Pharmaceuticals
₹2,118.50
+1.57%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does Beta Drugs Limited belong to?
Beta Drugs Limited operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.
What is the current share price of BETA?
As of the latest available quote, BETA traded at ₹2,118.50. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of BETA?
Beta Drugs Limited has a price-to-earnings (P/E) ratio of about 48.08. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of BETA?
The market capitalisation of Beta Drugs Limited is approximately ₹2,349 Cr.
Is Beta Drugs Limited profitable?
For its latest reported financial year, Beta Drugs Limited recorded a net profit margin of about 10.65%.
Does BETA pay a dividend?
Beta Drugs Limited does not currently show a dividend yield in our data.
What is the return on equity (ROE) of BETA?
Beta Drugs Limited has a return on equity (ROE) of about 18.80%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of BETA?
Over the past 52 weeks, BETA has traded between a low of ₹990.10 and a high of ₹2,807.90.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.